BIO-RAD LABORATORIES, INC. (BIO) — Institutional Holders, Q2 2026 (page 5)

403 institutional investment managers reported a BIO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $5.7B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 401 to 403. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

← BIO stock profile

BIO 13F holders ranked 401–403 of 403

Institutional investors reporting a position in BIO-RAD LABORATORIES, INC. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
#	Institution	Shares	Value	% of portfolio	QoQShares vs Q1 2026
401	Navigoe#401 · 2 sh	2	$0.00	0.00%	New
402	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#402 · 20,766 sh	20,766	—	—	-5.3%
403	Elequin Securities#403 · 217 sh	217	—	—	New

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.